558 related articles for article (PubMed ID: 23947673)
1. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
3. Induction of toll-like receptors by Propionibacterium acnes.
Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
5. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
Kim J
Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes.
Lee SE; Kim JM; Jeong SK; Jeon JE; Yoon HJ; Jeong MK; Lee SH
Arch Dermatol Res; 2010 Dec; 302(10):745-56. PubMed ID: 20697725
[TBL] [Abstract][Full Text] [Related]
7. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
[TBL] [Abstract][Full Text] [Related]
8. The role of innate immunity in the pathogenesis of acne.
Koreck A; Pivarcsi A; Dobozy A; Kemény L
Dermatology; 2003; 206(2):96-105. PubMed ID: 12592074
[TBL] [Abstract][Full Text] [Related]
9. Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity.
Lee SE; Kim JM; Jeong SK; Choi EH; Zouboulis CC; Lee SH
J Invest Dermatol; 2015 Sep; 135(9):2219-2227. PubMed ID: 25880702
[TBL] [Abstract][Full Text] [Related]
10. What is new in the pathophysiology of acne, an overview.
Dréno B
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
[TBL] [Abstract][Full Text] [Related]
11. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
12. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
13. Does inflammatory acne result from imbalance in the keratinocyte innate immune response?
Grange PA; Weill B; Dupin N; Batteux F
Microbes Infect; 2010 Dec; 12(14-15):1085-90. PubMed ID: 20691803
[TBL] [Abstract][Full Text] [Related]
14. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model.
An HJ; Lee WR; Kim KH; Kim JY; Lee SJ; Han SM; Lee KG; Lee CK; Park KK
Int J Mol Med; 2014 Nov; 34(5):1341-8. PubMed ID: 25215662
[TBL] [Abstract][Full Text] [Related]
16. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
17. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes.
Jarrousse V; Castex-Rizzi N; Khammari A; Charveron M; Dréno B
Eur J Dermatol; 2007; 17(6):492-6. PubMed ID: 17951128
[TBL] [Abstract][Full Text] [Related]
18. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of biochemical and genetic classification of propionibacterium acnes strains isolated from skin lesions of patients with acne].
Kasprowicz A; Owczarek MM; Miedzobrodzki J; Białecka A
Med Dosw Mikrobiol; 2012; 64(3):203-10. PubMed ID: 23285774
[TBL] [Abstract][Full Text] [Related]
20. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.
Isard O; Knol AC; Ariès MF; Nguyen JM; Khammari A; Castex-Rizzi N; Dréno B
J Invest Dermatol; 2011 Jan; 131(1):59-66. PubMed ID: 20927124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
